NSPRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
InspireMD, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.44−0.02 (-3.34%)
Close on Oct 19, 2026
- Market cap
- $37.25M
- P/E (TTM)
- –
- Dividend yield
- –
InspireMD, Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CGuard [Member] | – | – | – | – | – | – | – | – | – | $1.15M | – | – |
| MGuard [Member] | – | – | – | – | – | – | – | – | – | $747.00K | – | – |
| M Guard Prime E P S [Member] | – | – | – | $48.00K | $186.00K | -$279.00K | $456.00K | $631.00K | $839.00K | $747.00K | – | – |
| C Guard E P S [Member] | – | – | $6.21M | $5.12M | $4.31M | $2.76M | $3.27M | $2.97M | $1.92M | $1.15M | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Countries [Member] | $4.06M | $3.42M | $3.38M | $2.95M | $2.57M | $1.18M | $1.94M | $1.54M | $1.31M | $821.00K | 45.2% | +18.7% |
| U.S. [Member] | $1.42M | $32.00K | – | – | – | – | – | – | – | – | 15.8% | +4328.1% |
| Germany | $1.23M | $926.00K | $896.00K | $866.00K | $948.00K | $708.00K | $727.00K | $855.00K | $551.00K | $691.00K | 13.7% | +33.2% |
| Italy | $1.23M | $1.22M | $1.20M | $970.00K | $981.00K | $596.00K | $686.00K | $632.00K | $557.00K | $382.00K | 13.7% | +0.7% |
| Poland | $1.04M | $694.00K | – | – | – | $219.00K | $370.00K | $219.00K | – | – | 11.5% | +49.3% |
| Brazil [Member] | – | – | – | – | – | – | – | – | – | $57.00K | – | – |
| Belarus | – | – | – | – | – | – | – | – | – | $134.00K | – | – |
| Russia [Member] | – | – | – | – | – | – | – | – | $343.00K | – | – | – |
| Russia | – | $713.00K | $738.00K | $381.00K | – | – | $272.00K | $351.00K | $343.00K | – | – | – |
From the segment and revenue-disaggregation notes of InspireMD's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.